What CSRC’s New Capital Market Measures Mean for Foreign Companies in China: 2026 Update

Date:

Share post:






What CSRC’s New Capital Market Measures Mean for Foreign Companies in China: 2026 Update


On July 24, 2026, the China Securities Regulatory Commission (Zhongguo Zhengjianhui, CSRC) announced a package of measures to channel medium- and long-term capital into the country’s A-share markets, responding to a sharp equity sell-off that erased ¥3.2 trillion in market value over two weeks. Here’s what it means for your China business.

Why It Matters

When China’s securities regulator signals a capital market opening, foreign companies should pay attention — not just as potential investors, but as businesses that may one day raise capital onshore. The CSRC’s July 24 announcement isn’t just about stabilizing stock prices. It’s part of a broader strategy to deepen China’s capital markets and make them more accessible to foreign institutional participants.

For your business, this matters on two timeframes. In the immediate term, the CSRC’s measures — which include relaxing restrictions on insurance funds, pension funds, and bank wealth-management products investing in equities — send a powerful signal that Beijing will not tolerate a disorderly market. A stable A-share market supports consumer confidence, corporate fundraising, and the overall investment climate in which your China operations sit. Over the medium term, the direction of travel is toward more channels for foreign capital to enter and exit China’s onshore markets.

The CSRC statement, issued by Chairman Wu Qing, specifically committed to “maintaining smooth market operations” and “guiding medium- and long-term capital into the market.” The Shanghai Composite Index had dropped 5.8% in the preceding two weeks, with turnover on the Shanghai and Shenzhen exchanges falling to ¥680 billion daily — down from the ¥1.1 trillion average in Q2 2026, according to Wind Information data cited by SCMP.

The Details

The CSRC’s package targets three categories of institutional capital that collectively manage over ¥80 trillion in assets. First, insurance funds: China’s insurers held ¥29.6 trillion in assets at end-2025, but only 12.4% was allocated to equities and equity funds — well below the 30% regulatory ceiling. The CSRC is now encouraging insurers to increase equity allocations, with a reported target of reaching at least 20% by end-2027.

Second, the national pension system. China’s basic pension fund, enterprise annuity funds, and the National Social Security Fund collectively managed ¥18.7 trillion as of Q1 2026. Their combined equity exposure stood at roughly 8%, compared with 30-40% for comparable OECD-country pension funds. The CSRC measures would raise pension equity caps in stages, potentially unlocking ¥1.5-2 trillion in incremental equity investment over the next three years.

Third, and most relevant to foreign companies, the CSRC announced it would “further open channels for foreign institutional investors” and “optimize the Qualified Foreign Institutional Investor (QFII) and RMB Qualified Foreign Institutional Investor (RQFII) regimes.” As of June 2026, 742 foreign institutions held QFII/RQFII quotas totaling $116 billion, but actual utilization averaged only 62%, partly due to repatriation restrictions and registration friction that the new measures aim to address.

The regulator also flagged plans to expand the Stock Connect programs linking Shanghai, Shenzhen, and Hong Kong. Northbound trading through Stock Connect averaged ¥96 billion daily in H1 2026, up from ¥78 billion in H1 2025. The CSRC is considering raising daily quota limits and adding Exchange-Traded Funds (ETFs) to the Connect program — moves that would give foreign investors more efficient access to China’s onshore equity and bond markets.

These measures follow a pattern. In April 2026, the State Council issued guidelines on “Promoting High-Quality Development of the Capital Market,” which explicitly called for increasing the proportion of medium- and long-term capital in A-shares. The CSRC’s July package is the operational follow-through on that policy directive.

What You Should Do

The CSRC’s capital-market opening may feel distant from your day-to-day China operations, but it has tangible implications for foreign companies at every stage:

  • If you’re already operating in China: A deeper, more liquid onshore capital market means more financing options. Chinese banks have tightened corporate lending standards for seven consecutive quarters through Q2 2026, according to PBOC surveys. Onshore equity and bond markets offer alternatives, especially as CSRC makes them more foreign-accessible.
  • If you’re considering a China IPO or onshore listing: The CSRC’s push for medium- and long-term capital is designed to create a more stable investor base for new listings. The STAR Market’s average post-IPO 30-day volatility fell from 42% in 2024 to 28% in H1 2026 as institutional participation grew — a trend these measures should accelerate.
  • If you manage RMB cash reserves: Broader QFII access and Stock Connect expansion give you more options for RMB-denominated investment. Instead of parking excess RMB in 1.5% time deposits, you could access a broader range of onshore fixed-income and equity products.
  • If you’re watching the macro environment: CSRC’s commitment to market stability is effectively a government backstop for investor confidence. When the regulator says it will “guide capital” into markets, it’s deploying state-directed institutional firepower — a signal that should factor into your China risk assessment.

The Number to Remember: 12.4%

The number to remember: 12.4%. That’s the proportion of China’s ¥29.6 trillion insurance assets currently allocated to equities — less than half the regulatory ceiling of 30%. Closing even one-third of that gap would channel approximately ¥1.7 trillion into A-share markets. For foreign companies, that’s not just a number — it’s the depth of the institutional investor pool that could one day buy your onshore bonds, anchor your STAR Market IPO, or provide the market liquidity that makes China a viable capital-raising destination.

Where to Go From Here

Based on what you just read:

For more on how China is reshaping its investment landscape for foreign participants, see our coverage of the 2026 Investment Policy Blitz and our analysis of recent capital market opening announcements.

— China Gateway 360 —
Remote China market entry support, built around execution.


Related articles

How to Classify Products Under China’s HS Tariff System for Foreign Businesses

How to Classify Products Under China's HS Tariff System for Foreign Businesses China’s Harmonized System (HS) tariff system covers over 5,100 eight‑di

How to Calculate China Import Duties for Foreign Companies: 2026 Guide

How to Calculate China Import Duties for Foreign Companies: 2026 Guide In 2026, a foreign company importing goods into China faces a combined duty str

How Global GLP-1 Drug Demand Is Fueling China’s Pharma CDMO Boom: 2026 Update

WuXi AppTec's shares surged 37% in H1 2026 as global GLP-1 weight-loss drug orders flooded China's CDMO sector. With peptide reactor capacity growing twelvefold to 100,000 liters, here's what the pharma manufacturing boom means for your foreign biotech or pharmaceutical business.

What China’s Money-Market Rate Loan Pilot Means for Foreign Companies: 2026 Update

China's central bank launched a pilot program in Hainan pricing bank loans against the DR007 money-market rate instead of LPR, signaling a multi-year shift in how RMB borrowing costs are determined. Here's what foreign companies with RMB-denominated debt should do now.